about
Tumor-extracellular matrix interactions: Identification of tools associated with breast cancer progressionAccurate data processing improves the reliability of Affymetrix gene expression profiles from FFPE samplesCell cycle dependent oscillatory expression of estrogen receptor-α links Pol II elongation to neoplastic transformationUse of formalin-fixed paraffin-embedded samples for gene expression studies in breast cancer patientsmiR-30e* is an independent subtype-specific prognostic marker in breast cancerIn-depth characterization of breast cancer tumor-promoting cell transcriptome by RNA sequencing and microarraysOncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer.Gene expression profiling of circulating tumor cells in breast cancer.Detection of Circulating Tumour Cells in Urothelial Cancers and Clinical Correlations: Comparison of Two Methods.How to study and overcome tumor heterogeneity with circulating biomarkers: The breast cancer case.Strategies to translate preclinical information to breast cancer patient benefit.Clinical Significance of Early Changes in Circulating Tumor Cells from Patients Receiving First-Line Cisplatin-Based Chemotherapy for Metastatic Urothelial Carcinoma.Patterns and changes in gene expression following neo-adjuvant anti-estrogen treatment in estrogen receptor-positive breast cancer.Ten-year results of applying an original scoring system for addressing adjuvant therapy use after breast-conserving surgery for ductal carcinoma in situ of the breast.Subtype-dependent prognostic relevance of an interferon-induced pathway metagene in node-negative breast cancer.Prognostic and functional role of subtype-specific tumor-stroma interaction in breast cancer.Prognostic relevance of pS2 status in association with steroid receptor status and proliferative activity in node-negative breast cancer.Selective modulation of ER-beta by estradiol and xenoestrogens in human breast cancer cell lines.Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer.Dissecting Time- from Tumor-Related Gene Expression Variability in Bilateral Breast Cancer.Metabolic Footprints and Molecular Subtypes in Breast Cancer.PIK3CA cancer mutations display gender and tissue specificity patterns.TARIBO trial: targeted therapy with or without nephrectomy in metastatic renal cell carcinoma: liquid biopsy for biomarkers discovery.Circulating Biomarkers for Prediction of Treatment Response.Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory, RAS-BRAF wild-type colorectal cancer receiving cetuximab or panitumumab.Subtype-Specific Metagene-Based Prediction of Outcome after Neoadjuvant and Adjuvant Treatment in Breast Cancer.Estrogen Receptor-Beta Expression in Hereditary Breast CancerDid Circulating Tumor Cells Tell us all they Could? The Missed Circulating Tumor Cell Message in Breast CancerPrognostic relevance of cathepsin D versus oestrogen receptors in node negative breast cancersSimultaneous estimation of epidermal growth factor receptors and steroid receptors in a series of 136 resectable primary breast tumorsRelationship between ER-ICA and conventional steroid receptor assays in human breast cancerProgesterone receptor determination in human breast tumors by immunocytochemical and biochemical techniquesQuantitative immunohistochemical determination of cathepsin-D and its relation with other variablesp53 as an independent prognostic marker in lymph node-negative breast cancer patientsParacrine interaction in co-culture of hormone-dependent and independent breast cancer cellsGenistein in the control of breast cancer cell growth: insights into the mechanism of action in vitroExtracellular matrix proteins as diagnostic markers of breast carcinomaTailoring treatment of salivary duct carcinoma (SDC) by liquid biopsy: ARv7 expression in circulating tumor cellsAnalysis of Single Circulating Tumor Cells in Renal Cell Carcinoma Reveals Phenotypic Heterogeneity and Genomic Alterations Related to ProgressionA novel circulating tumor cell subpopulation for treatment monitoring and molecular characterization in biliary tract cancer
P50
Q26785362-32B88127-6C55-4BA4-ADD4-C9CF06334E12Q30747169-480F156D-A30D-4167-AFB0-EF99CD1C7A3DQ33854262-BB9E2227-9C8A-40CA-954C-849269C212CDQ35284791-54EB00F6-E3E9-4B7F-8ACF-EF36A801552BQ35863168-6A61821E-C578-4562-93DE-505F3D636F3CQ36729581-62340C54-690E-4E4E-93E0-1217ACEE7AC4Q37018223-365584A9-4272-41FC-A7FC-1F7DD7EBC788Q38470332-8921F598-B42F-4DBF-AD57-9D91A6A01C08Q38711439-E6421066-1D8F-4040-AC88-91144FA7075BQ39262168-ADEBC6CD-92D7-4992-8BD9-5DD48651BB42Q39449788-7CF8A120-0EB2-43BB-B1AA-99227FAB9941Q39775377-0062B31C-C656-4816-9BC9-DC2737C872E0Q39977561-5BFA91A0-8956-432B-AE56-D32BA3BE4F85Q40145267-9B217215-E72F-45BD-B9FC-C327FDC19CA8Q41135122-0D7486F1-E7B6-46A9-BA93-B84DC7B7ECA3Q41880628-0BB0BD03-5B3B-4250-B27A-DB45E02B390FQ44298561-884D8D8D-B40E-426C-B749-E55D51CD9E9EQ44434114-642A6A0B-263A-4436-ADFF-3719013F606DQ45333964-E4D9C865-A25D-4746-88EF-97BF4FB6021FQ48284400-DA13A928-0C96-4B1D-B34D-ADBE6CC1095EQ49871101-94859B0E-1BB3-4052-B4EE-B8442EB5D062Q51727532-1DEEABC7-0CA2-4103-BD1B-72CE2C2B21AEQ52764218-04AFD96A-C23F-47BE-8370-24ED35CBA1ABQ53471686-C0DCAAC4-B45A-4830-89C0-775C6FD9C5F3Q54288887-D9AB3AAD-316A-4A8C-9A55-28230B8DACC6Q55041652-2DE8959F-2ADB-4055-9692-8ECB5C3CEB4AQ56928445-2BF45D78-6BC8-4448-8741-9E8D0E89B6D0Q60168333-55EEB466-A1DC-459B-AC05-40AE152554CDQ67902985-8A56B4C0-2AB7-45E1-A516-978106DF9F1AQ68513875-0933F9AE-05BB-4544-882B-2878DA23A9D1Q68921914-8D34463D-E492-4BD5-AB10-65637CA26865Q69562519-DAD2492E-9C36-4D74-B696-BDB29CC0BF8CQ70483066-F71176A3-59D7-41D2-A327-A4F09024AE5FQ70724953-891CFD12-5FDD-43E7-98F1-31AE42B313ACQ72634659-9616CD97-FD94-4CD5-8EFB-CB1344D32A1EQ77342025-2ACB2D9E-6D96-4C41-AFFF-7ADEF1934BA7Q88009805-ED428CC8-98BF-42F0-B763-96A5EEA97127Q89088209-CCA344D4-7497-4BC3-AE9D-D46694FF31ACQ89879312-D5B688CF-EC94-4342-8C4B-6A668998759FQ91784242-A514381B-4269-4A7C-AAEC-41C9297928A6
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Vera Cappelletti
@ast
Vera Cappelletti
@en
Vera Cappelletti
@es
Vera Cappelletti
@nl
Vera Cappelletti
@sl
type
label
Vera Cappelletti
@ast
Vera Cappelletti
@en
Vera Cappelletti
@es
Vera Cappelletti
@nl
Vera Cappelletti
@sl
prefLabel
Vera Cappelletti
@ast
Vera Cappelletti
@en
Vera Cappelletti
@es
Vera Cappelletti
@nl
Vera Cappelletti
@sl
P1053
B-9310-2017
P106
P1153
7003932016
P21
P31
P3829
P496
0000-0002-9709-0676